パニツムマブの世界市場 2020年

• 英文タイトル：Global Panitumumab Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114769 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、パニツムマブの世界市場を調査対象にし、パニツムマブの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（100 mg/5 mL単回投与バイアル、400 mg/20 mL単回投与バイアル）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Amgen ・企業別売上、市場シェア ・パニツムマブの地域別市場分析 ・パニツムマブの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・パニツムマブのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・パニツムマブのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・パニツムマブの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・パニツムマブの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・パニツムマブの種類別市場規模2015-2020：100 mg/5 mL単回投与バイアル、400 mg/20 mL単回投与バイアル ・パニツムマブの用途別市場規模2015-2020：病院、ドラッグストア ・パニツムマブの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Panitumumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Panitumumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Panitumumab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Panitumumab market has been segmented into:
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials

By Application, Panitumumab has been segmented into:
Hospital
Drug store

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Panitumumab market presented in the report. This section sheds light on the sales growth of different regional and country-level Panitumumab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Panitumumab market.

The report offers in-depth assessment of the growth and other aspects of the Panitumumab market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Panitumumab Market Share Analysis
Panitumumab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Panitumumab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Panitumumab sales, revenue and market share for each player covered in this report.

The major players covered in Panitumumab are:
Amgen

レポート目次

---

1 Panitumumab Market Overview
1.1 Product Overview and Scope of Panitumumab
1.2 Classification of Panitumumab by Type
1.2.1 Global Panitumumab Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Panitumumab Revenue Market Share by Type in 2019
1.2.3 100 mg/5 mL single-dose vials
1.2.4 400 mg/20 mLsingle-dose vials
1.3 Global Panitumumab Market by Application
1.3.1 Overview: Global Panitumumab Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Panitumumab Market by Regions
1.4.1 Global Panitumumab Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Panitumumab (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Panitumumab Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Panitumumab Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panitumumab Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Panitumumab Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panitumumab Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Panitumumab Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Panitumumab Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Panitumumab Players Market Share
3.2.2 Top 10 Panitumumab Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Panitumumab Revenue and Market Share by Regions
4.2 North America Panitumumab Revenue and Growth Rate (2015-2020)
4.3 Europe Panitumumab Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Panitumumab Revenue and Growth Rate (2015-2020)
4.5 South America Panitumumab Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Panitumumab Revenue and Growth Rate (2015-2020)
5 North America Panitumumab Revenue by Countries
5.1 North America Panitumumab Revenue by Countries (2015-2020)
5.2 USA Panitumumab Revenue and Growth Rate (2015-2020)
5.3 Canada Panitumumab Revenue and Growth Rate (2015-2020)
5.4 Mexico Panitumumab Revenue and Growth Rate (2015-2020)
6 Europe Panitumumab Revenue by Countries
6.1 Europe Panitumumab Revenue by Countries (2015-2020)
6.2 Germany Panitumumab Revenue and Growth Rate (2015-2020)
6.3 UK Panitumumab Revenue and Growth Rate (2015-2020)
6.4 France Panitumumab Revenue and Growth Rate (2015-2020)
6.5 Russia Panitumumab Revenue and Growth Rate (2015-2020)
6.6 Italy Panitumumab Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Panitumumab Revenue by Countries
7.1 Asia-Pacific Panitumumab Revenue by Countries (2015-2020)
7.2 China Panitumumab Revenue and Growth Rate (2015-2020)
7.3 Japan Panitumumab Revenue and Growth Rate (2015-2020)
7.4 Korea Panitumumab Revenue and Growth Rate (2015-2020)
7.5 India Panitumumab Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Panitumumab Revenue and Growth Rate (2015-2020)
8 South America Panitumumab Revenue by Countries
8.1 South America Panitumumab Revenue by Countries (2015-2020)
8.2 Brazil Panitumumab Revenue and Growth Rate (2015-2020)
8.3 Argentina Panitumumab Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Panitumumab by Countries
9.1 Middle East & Africa Panitumumab Revenue by Countries (2015-2020)
9.2 Saudi Arabia Panitumumab Revenue and Growth Rate (2015-2020)
9.3 UAE Panitumumab Revenue and Growth Rate (2015-2020)
9.4 Egypt Panitumumab Revenue and Growth Rate (2015-2020)
9.5 South Africa Panitumumab Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Panitumumab Revenue and Market Share by Type (2015-2020)
10.2 Global Panitumumab Market Forecast by Type (2019-2024)
10.3 100 mg/5 mL single-dose vials Revenue Growth Rate (2015-2025)
10.4 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2015-2025)
11 Global Panitumumab Market Segment by Application
11.1 Global Panitumumab Revenue Market Share by Application (2015-2020)
11.2 Panitumumab Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug store Revenue Growth (2015-2020)
12 Global Panitumumab Market Size Forecast (2021-2025)
12.1 Global Panitumumab Market Size Forecast (2021-2025)
12.2 Global Panitumumab Market Forecast by Regions (2021-2025)
12.3 North America Panitumumab Revenue Market Forecast (2021-2025)
12.4 Europe Panitumumab Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Panitumumab Revenue Market Forecast (2021-2025)
12.6 South America Panitumumab Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Panitumumab Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Panitumumab Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Panitumumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Panitumumab Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Panitumumab Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amgen Corporate Information, Location and Competitors
Table 6. Amgen Panitumumab Major Business
Table 7. Amgen Panitumumab Total Revenue (USD Million) (2017-2018)
Table 8. Amgen SWOT Analysis
Table 9. Amgen Panitumumab Product and Solutions
Table 10. Amgen Panitumumab Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Panitumumab Revenue (Million USD) by Players (2015-2020)
Table 12. Global Panitumumab Revenue Share by Players (2015-2020)
Table 13. Global Panitumumab Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Panitumumab Revenue Market Share by Regions (2015-2020)
Table 15. North America Panitumumab Revenue by Countries (2015-2020)
Table 16. North America Panitumumab Revenue Market Share by Countries (2015-2020)
Table 17. Europe Panitumumab Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Panitumumab Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Panitumumab Revenue by Countries (2015-2020)
Table 20. South America Panitumumab Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Panitumumab Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Panitumumab Revenue Market Share by Countries (2015-2020)
Table 23. Global Panitumumab Revenue (Million USD) by Type (2015-2020)
Table 24. Global Panitumumab Revenue Share by Type (2015-2020)
Table 25. Global Panitumumab Revenue Forecast by Type (2021-2025)
Table 26. Global Panitumumab Revenue by Application (2015-2020)
Table 27. Global Panitumumab Revenue Share by Application (2015-2020)
Table 28. Global Panitumumab Revenue Forecast by Application (2021-2025)
Table 29. Global Panitumumab Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Panitumumab Picture
Figure 2. Global Panitumumab Revenue Market Share by Type in 2019
Figure 3. 100 mg/5 mL single-dose vials Picture
Figure 4. 400 mg/20 mLsingle-dose vials Picture
Figure 5. Panitumumab Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Panitumumab Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Panitumumab Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Panitumumab Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Panitumumab Revenue Market Share in 2019
Figure 17. Global Top 10 Players Panitumumab Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Panitumumab Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Panitumumab Revenue Market Share by Regions (2015-2020)
Figure 21. Global Panitumumab Revenue Market Share by Regions in 2018
Figure 22. North America Panitumumab Revenue and Growth Rate (2015-2020)
Figure 23. Europe Panitumumab Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Panitumumab Revenue and Growth Rate (2015-2020)
Figure 25. South America Panitumumab Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Panitumumab Revenue and Growth Rate (2015-2020)
Figure 27. North America Panitumumab Revenue Market Share by Countries (2015-2020)
Figure 28. North America Panitumumab Revenue Market Share by Countries in 2019
Figure 29. USA Panitumumab Revenue and Growth Rate (2015-2020)
Figure 30. Canada Panitumumab Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Panitumumab Revenue and Growth Rate (2015-2020)
Figure 32. Europe Panitumumab Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Panitumumab Revenue Market Share by Countries in 2019
Figure 34. Germany Panitumumab Revenue and Growth Rate (2015-2020)
Figure 35. UK Panitumumab Revenue and Growth Rate (2015-2020)
Figure 36. France Panitumumab Revenue and Growth Rate (2015-2020)
Figure 37. Russia Panitumumab Revenue and Growth Rate (2015-2020)
Figure 38. Italy Panitumumab Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Panitumumab Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Panitumumab Revenue Market Share by Countries in 2019
Figure 41. China Panitumumab Revenue and Growth Rate (2015-2020)
Figure 42. Japan Panitumumab Revenue and Growth Rate (2015-2020)
Figure 43. Korea Panitumumab Revenue and Growth Rate (2015-2020)
Figure 44. India Panitumumab Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Panitumumab Revenue and Growth Rate (2015-2020)
Figure 46. South America Panitumumab Revenue Market Share by Countries (2015-2020)
Figure 47. South America Panitumumab Revenue Market Share by Countries in 2019
Figure 48. Brazil Panitumumab Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Panitumumab Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Panitumumab Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Panitumumab Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Panitumumab Revenue and Growth Rate (2015-2020)
Figure 53. UAE Panitumumab Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Panitumumab Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Panitumumab Revenue and Growth Rate (2015-2020)
Figure 56. Global Panitumumab Revenue Share by Type (2015-2020)
Figure 57. Global Panitumumab Revenue Share by Type in 2019
Figure 58. Global Panitumumab Market Share Forecast by Type (2021-2025)
Figure 59. Global 100 mg/5 mL single-dose vials Revenue Growth Rate (2015-2020)
Figure 60. Global 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2015-2020)
Figure 61. Global Panitumumab Revenue Share by Application (2015-2020)
Figure 62. Global Panitumumab Revenue Share by Application in 2019
Figure 63. Global Panitumumab Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drug store Revenue Growth Rate (2015-2020)
Figure 66. Global Panitumumab Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Panitumumab Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Panitumumab Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Panitumumab Revenue Market Forecast (2021-2025)
Figure 70. Europe Panitumumab Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Panitumumab Revenue Market Forecast (2021-2025)
Figure 72. South America Panitumumab Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Panitumumab Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---